Raymond James Downgrades Alignment Healthcare Inc (ALHC) to Outperform

Raymond James analyst John Ransom downgraded Alignment Healthcare Inc (NASDAQ: ALHC) from Strong Buy to Outperform with a price target of $19.00 (from $22.00).

The analyst comments "We are downgrading our rating on ALHC to Outperform and lowering our price target to $19. While we continue to see long-term value in the operating model, and believe the company has earned credibility due to its track record of consistent execution during a tough operating environment over the last few years, visibility into the trajectory of earnings is less clear as the company continues to expand outside of California and into new markets, likely leading to increased investment spend and less predictability into earnings. Additionally, the large amount of SNP members that the company is adding (~25K YTD, 43% of new members) is pressuring MLR around the edges in an MA setup where we’d expect a bit more outperformance. While 2Q26 earnings were better than expected (even excluding the $6M of sweep payments) and the full-year guide was raised by ~$3.5M, the quarter did feature $6.5M of negative PPD which is not a favorable signal, and the company is spending down 2H earnings to pull forward investments in new markets, something the market has not been rewarding of late. The stock is off ~40% from its recent peak, and is now trading at a more reasonable level in our view (~12x P/E on our hypothetical 2030 EPS discounted back 2 years), although valuation is admittedly difficult here given the relatively low GAAP EPS. We continue to like ALHC long term for its solid operations, differentiated tech platform, and growth potential, but our visibility into earnings over the next 12 months is less clear than normal."

For an analyst ratings summary and ratings history on Alignment Healthcare Inc click here. For more ratings news on Alignment Healthcare Inc click here.

Shares of Alignment Healthcare Inc closed at $14.85 yesterday.

You May Also Be Interested In

• Tempus AI Inc (TEM) PT Lowered to $70 at BTIG
• Johnson & Johnson (JNJ) PT Raised to $280 at Raymond James
• Trump: Exxon, Chevron Are Making Too Much Money